July 25, 2025 · Form 4 insider transaction
Title 19 Promis bought 119,800 shares of PROMIS NEUROSCIENCES INC, a transaction worth N/A. The trade was recorded as exercise of in-the-money option and disclosed on an SEC Form 4, filed 4 days after the transaction.
On July 25, 2025, Title 19 Promis exercised 119,800 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by Title 19 Promis and an acceptance by the Issuer, were exercised at an exercise price of $0.83158 per share. The remainder of these warrants are currently exercisable and expire on the earlier of (i) 18 months of the issue date and (ii) within 60 days of the public announcement via press release or the filing of a Current Report on Form 8-K of 6-month data from the cohorts treated with single ascending doses of PMN310.